Australia markets closed

Diamyd Medical AB (publ) (DMN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.8600+0.0040 (+0.47%)
As of 08:15AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in SEK. All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
634
546
454
253
341
Cost of revenue
4,364
3,634
4,403
2,501
4,488
Gross profit
-3,730
-3,088
-3,949
-2,248
-4,147
Operating expenses
Research development
66,006
69,909
75,567
56,860
13,810
Selling general and administrative
-
-
11,669
9,457
6,858
Total operating expenses
104,405
112,758
110,987
83,633
-13,887
Operating income or loss
-108,135
-115,846
-114,936
-85,881
9,740
Interest expense
184
3
253
453
530
Income before tax
-98,704
-116,074
-103,516
60,045
9,709
Income tax expense
0
0
0
0
0
Income from continuing operations
-98,704
-116,074
-103,516
60,045
9,709
Net income
-98,705
-116,073
-103,517
60,046
9,709
Net income available to common shareholders
-98,705
-116,073
-103,517
60,046
9,709
Basic EPS
-1.50
-1.46
-1.37
0.88
0.10
Diluted EPS
-1.50
-1.46
-1.37
0.88
0.10
Basic average shares
78,286
80,182
78,385
71,485
70,845
Diluted average shares
78,286
80,182
78,385
71,485
70,845